People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Unity Biotechnology, Inc. | — | Biotechnology | Series D+ | $208.6M | $2.3B | 2018 |
Bob E. Goeltz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bob E. Goeltz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Kristina Burow | 1 | 16 |
| Troy Foster | 1 | 5 |
| Robert E. Nelsen | 1 | 3 |
| Nathaniel David | 1 | 3 |
| Kristina E. Burow | 1 | 2 |
| Graham E. Cooper | 1 | 2 |
| Nathaniel E. David | 1 | 1 |
| John E. Smither | 1 | 1 |
| Keith E. Klein | 1 | 1 |
| Dan E. Marquess | 1 | 1 |
| Keith E. Leonard | 1 | 1 |
| Tamara E. Tompkins | 1 | 1 |
| Paul E. Berns | 1 | 1 |
| Camille E. Samuels | 1 | 1 |
| Jamie E. Dananberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.